Nalaganje...
Metformin and metabolic diseases: a focus on hepatic aspects
Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochem...
Shranjeno v:
| izdano v: | Front Med |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4567274/ https://ncbi.nlm.nih.gov/pubmed/25676019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11684-015-0384-0 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|